rdf:type |
|
lifeskim:mentions |
umls-concept:C0010583,
umls-concept:C0013216,
umls-concept:C0027497,
umls-concept:C0040808,
umls-concept:C0042963,
umls-concept:C0061851,
umls-concept:C0079083,
umls-concept:C0184511,
umls-concept:C1140680,
umls-concept:C1516213,
umls-concept:C2587213
|
pubmed:issue |
2
|
pubmed:dateCreated |
1996-8-1
|
pubmed:abstractText |
Ondansetron was found to be effective as an antiemetic in numerous clinical trials of highly emetogenic combination-chemotherapy regimens that included cisplatin. Its role in milder emetogenic regimes has not been fully defined.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-2936
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
114-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8654467-Antiemetics,
pubmed-meshheading:8654467-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8654467-Bromazepam,
pubmed-meshheading:8654467-Cisplatin,
pubmed-meshheading:8654467-Cyclophosphamide,
pubmed-meshheading:8654467-Drug Administration Schedule,
pubmed-meshheading:8654467-Drug Therapy, Combination,
pubmed-meshheading:8654467-Electrolytes,
pubmed-meshheading:8654467-Female,
pubmed-meshheading:8654467-Humans,
pubmed-meshheading:8654467-Middle Aged,
pubmed-meshheading:8654467-Nausea,
pubmed-meshheading:8654467-Ondansetron,
pubmed-meshheading:8654467-Ovarian Neoplasms,
pubmed-meshheading:8654467-Prospective Studies,
pubmed-meshheading:8654467-Vomiting
|
pubmed:year |
1996
|
pubmed:articleTitle |
Improved control of nausea and emesis with a new bromazepam-containing ondansetron regimen in ovarian cancer patients receiving chemotherapy with carboplatin and cyclophosphamide.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Göttingen, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|